PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (FR0010949404 – STNT), a medical technology company commercializing in Europe the world’s first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), today presented the final terms of the acquisition of Cappella Peel Away Inc. (Delaware, USA) and of its assets relating to a novel stent delivery system for a total amount of €1 million in stock and cash.
Help employers find you! Check out all the jobs and post your resume.
